A major pharmaceutical company, facing potential regulatory…

A mаjоr phаrmаceutical cоmpany, facing pоtential regulatory changes that would lower drug prices, funds a public relations campaign. This campaign uses a shell organization to pay individuals to attend town hall meetings, write letters to the editor using provided templates, and create social media groups claiming to be a "grassroots patient advocacy coalition." This strategy, intended to deceptively create the appearance of widespread public support for the pharmaceutical company's position, is best known as: